News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Brewis Neil
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/09/2023 |
4
| Brewis Neil (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Unknown transaction of 105,088 shares
@ $7.12, valued at
$748.2k
Disposed/sold 9,375 shares
@ $7.12, valued at
$66.8k
Disposed/sold 22,561 options to buy
@ $7.24, valued at
$163.3k
Disposed/sold 74,263 options to buy
@ $4.77, valued at
$354.2k
Disposed/sold 132,469 options to buy
@ $3.55, valued at
$470.3k
|
|
| 08/02/2022 |
4
| Brewis Neil (Chief Scientific Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Exercised 76,619 shares
@ $0.11, valued at
$8.4k
Exercised 6,307 options to buy
@ $0
Exercised 70,312 options to buy
@ $0 |
|
| 04/04/2022 |
4
| Brewis Neil (Chief Scientific Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 132,469 options to buy
@ $3.55, valued at
$470.3k
|
|
| 01/11/2022 |
4
| Brewis Neil (Chief Scientific Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 74,263 options to buy
@ $4.77, valued at
$354.2k
|
|
| 03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Brewis Neil (Chief Scientific Officer) has filed a Form 4 on F-star Therapeutics, Inc.|
Txns:
| Granted 19,844 shares
@ $0
Granted 6,307 options to buy
@ $0
Granted 70,312 options to buy
@ $0 |
|
|
|